Graduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China, 100029.
Department of Traditional Chinese Medicine for Pulmonary Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2023 Dec 22;18:3049-3065. doi: 10.2147/COPD.S425735. eCollection 2023.
Although studies on the association between COPD and lung cancer are of great significance, no bibliometric analysis has been conducted in the field of their comorbidity. This bibliometric analysis explores the current situation and frontier trends in the field of COPD and lung cancer comorbidity, and to lay a new direction for subsequent research.
Articles in the field of COPD and cancer comorbidity were retrieved from Web of Science Core Collections (WoSCC) from 2004 to 2023, and analyzed by VOSviewer, CiteSpace, Biblimatrix and WPS Office.
In total, 3330 publications were included. The USA was the leading country with the most publications and great influence. The University of Groningen was the most productive institution. Edwin Kepner Silverman was the most influential scholar in this field. PLOS One was found to be the most prolific journal. Mechanisms and risk factors were of vital importance in this research field. Environmental pollution and pulmonary fibrosis may be future research prospects.
This bibliometric analysis provided new guidance for the development of the field of COPD and lung cancer comorbidity by visualizing current research hotspots, and predicting possible hot research directions in the future.
尽管关于 COPD 和肺癌相关性的研究具有重要意义，但针对两者共病领域尚未进行任何文献计量分析。本研究通过文献计量分析，探讨 COPD 和肺癌共病领域的现状和前沿趋势，为后续研究开辟新的方向。
检索 2004 年至 2023 年 Web of Science 核心合集（WoSCC）中 COPD 和癌症共病领域的文章，采用 VOSviewer、CiteSpace、Biblimatrix 和 WPS Office 进行分析。
共纳入 3330 篇文献。美国是发表文献数量最多、影响力最大的国家。研究机构中，格罗宁根大学的发文量最多。在该领域，Edwin Kepner Silverman 是最具影响力的学者。PLOS One 是发文量最多的期刊。该领域的研究热点包括发病机制和风险因素。未来可能的研究方向包括环境污染和肺纤维化。
本研究通过对 COPD 和肺癌共病领域的研究热点进行可视化，预测未来可能的热点研究方向，为该领域的发展提供了新的指导。
